Daniel Finan, a prolific inventor based in Philadelphia, PA, has made significant strides in the field of diabetes management through his eight patents. His groundbreaking inventions are shaping the future of insulin delivery systems, focusing on maximizing efficacy and improving patient outcomes.

Latest Patents

Among his latest patents, Daniel has developed two notable innovations. The first patent addresses maintaining maximum dosing limits for closed-loop insulin management systems. This technology consists of an infusion pump, a glucose sensor, and a controller programmed to optimize insulin delivery according to various stored variables. The controller calculates the maximum insulin delivery rate based on the default basal insulin delivery rate, temporary basal insulin delivery rate, extended bolus rate, or a combination of these factors.

The second patent revolves around a diabetes management system featuring automatic basal and manual bolus insulin control. This exemplary system consists of a delivery device and a glucose sensor, where the glucose sensor continuously measures the subject's glucose levels. The basal insulin dose is determined through a model predictive control algorithm, which utilizes physiological data such as desired glucose levels and the amounts of delivered insulin. Furthermore, the system enables the subject to initiate a manual bolus insulin dose, which is then adjusted using the model predictive control algorithm and physiological data to optimize the total insulin delivery to the subject.

Career Highlights

Throughout his career, Daniel Finan has contributed to prominent companies such as Animas Corporation and Lifescan IP Holdings, LLC. His work at these organizations has been instrumental in advancing the technology behind insulin management and improving the lives of individuals with diabetes.

Collaborations

Daniel has also collaborated with notable professionals, including Thomas McCann, Jr. and Pavel Vereshchetin. These partnerships have allowed for the exchange of ideas and expertise, further enhancing the development of innovative solutions in diabetes care.

Conclusion

Daniel Finan exemplifies the innovative spirit required to propel the field of diabetes management forward. With his numerous patents and collaborations, he continues to provide valuable contributions that make significant impacts on the lives of diabetic patients. His work not only reflects his dedication to innovation but also highlights the potential for continued advancements in medical technology.

This text is generated by artificial intelligence and may not be accurate.